Firefly $FLY Hikes IPO Range to $43 Amid Strong Demand,...
Key Takeaways Firefly Aerospace has increased its IPO price range to $41-$43 per share, pointing to strong investor demand and a potential valuation of up to $6.04 billion. The offering...
Macro Watch
2273 results found
Eli Lilly’s New Pill Loses Market Lead to Novo Nordisk’s...
Key Takeaways Eli Lilly’s orforglipron and Novo Nordisk’s oral semaglutide are locked in a competitive battle for supremacy in the lucrative oral weight-loss drug market. Clinical trial data shows nuanced...
AST SpaceMobile $ASTS Bulls Eye $78 Target Amid 120% Surge
Key Takeaways AST SpaceMobile’s stock has surged over 120% from its March 2025 lows, rewarding investors who adopted a long-term “hold” strategy. Analyst price targets have been consistently revised upwards,...
ChatGPT User Surge: 700 Million Weekly, Quadruples Year-on-Year, Boosts OpenAI...
Key Takeaways ChatGPT’s user base is projected to quadruple to 700 million weekly active users, indicating a significant shift from a novel technology to an indispensable global tool. The surge...
Novo Nordisk $NVO: Market Overreaction or Contrarian Buy Opportunity?
Key Takeaways The market has reacted with extreme pessimism to Novo Nordisk’s revised 2025 guidance, causing its stock price to fall nearly 70% from its all-time high. This negative sentiment...
AMD $AMD Releases MI350 Chips, Prices Surge 67% Amid Strong...
Key Takeaways AMD has initiated shipments of its MI350 series accelerators, a critical milestone in its strategy to gain market share in the AI hardware sector. The company has reportedly...
Dave Inc. $DAVE Raises Annual Guidance; Key Metric RPU in...
Key Takeaways Dave Inc.’s upgraded 2025 guidance has raised investor expectations, placing intense focus on the upcoming second-quarter results to validate its optimistic projections. The company’s straightforward business model, centred...
TransMedics $TMDX Boosted by FDA Approval for OCS Heart Trial...
Key Takeaways TransMedics has received FDA approval for a large-scale Investigational Device Exemption (IDE) trial for its next-generation OCS Heart system, involving over 650 patients. This follows a recent de...
ASML $ASML Dominates with Strategic Partnerships Despite Chinese Challenges
Key Takeaways ASML’s enduring competitive advantage is founded not just on its technology, but on deep, long-term collaborative partnerships with chipmakers which are difficult for rivals to replicate. Significant recurring...
Nebius $NBIS Achieves Top Inference Speeds on NVIDIA GPUs; Strategic...
Key Takeaways Nebius has established a new performance benchmark with AI inference speeds reaching 245 tokens per second for Llama 3.3 70B, achieved on standard, publicly available NVIDIA GPUs. This...
